Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Novel Multiplexed Protein Sensor Developed

By LabMedica International staff writers
Posted on 14 Aug 2013
A novel method has been developed for parallel protein analysis that is, in principle, capable of identifying hundreds or even thousands of different proteins.

The device is able to identify the specific proteins in the fluid and allows rapid and reliable differentiation between harmless microorganisms and dangerous pathogens. More...


Chemists at Johannes Gutenberg University (Mainz, Germany) have designed a sensor that is only of one-tenth of a square millimeter in area, but capable of performing a hundred different individual tests on that surface. The 'test strips' consist of glass capillary tubes that have gold nanoparticles as sensor elements on their internal surfaces. The test involves placing a tiny drop of blood, saliva, or other bodily fluid on a small test strip, which is then placed in the device.

The scientists used the simple and direct principle of plasmons in noble metal nanoparticles, which react to protein binding by a shift of the resonance wavelength. This is the target detection method for both the mapped and the unmapped sensors by monitoring individual nanoparticles by optical dark-field spectroscopy. The team used four different target proteins to demonstrate the viability of the concept, its ability to detect concentrations in the nanomolar range, and the possibility to recycle the sensors for more than one analysis.

The four proteins tested were thrombin, immunoglobulin E (IgE), streptavidin, and fibronectin. When a protein docks with one of these special DNA strands, called aptamers, the corresponding nanoparticle changes its color. The color changes can be detected with the aid of a spectrometer. For this purpose, the capillary tubes are placed under a microscope designed, constructed, and provided with the necessary software by the team of chemists. Low-cost serial production of the sensors is feasible if advanced nanofabrication methods such as nanoprinting or optical trapping are used.

Christina Rosman, DiplChem, first author of the study, said, “We have demonstrated a new approach for a multiplexed assay that detects multiple proteins simultaneously by letting a fluid flow past the randomly positioned gold nanorods. We see the potential to extend our method to the simultaneous detection of hundreds or even thousands of different target substances." There are manifold possible applications of a test for multiple targets in a single procedure. The low-cost sensors could be directly used by physicians in their practices in order to detect and discriminate various types of influenza viruses with which their patients could be infected. The study was published on June 21, 2013, in the journal Nano Letters.

Related Links:

Johannes Gutenberg University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.